Health Canada Recall Notice — Allerject
In consultation with Health Canada, a Canada-wide recall has been issued for all lots of the Allerject epinephrine auto-injectors by Sanofi Canada. A similar recall is taking place in the United States, where it’s sold as Auvi-Q.
Allerject is used as an emergency treatment by patients who are at risk and/or have a history of serious allergic reactions such as anaphylaxis. This recall is due to issues that may potentially affect the delivery of the required amount of epinephrine.
Please inform the parents of any student in your school using this product. Parents should contact their health care provider or pharmacist for more information about this recall.
More information about this recall is available on the Health Canada website or by contacting the Public Enquiries Line toll free at 1-866-225-0709.